Here’s what you need to know.
1. Dr. Czaja is an emeritus professor of medicine and an emeritus consultant in the division of gastroenterology and hepatology at the Mayo Clinic.
2. Dr. Czaja retired from practice in 2007, but is a renowned researcher.
3. Dr. Czaja is a leading authority on autoimmune liver disease and has made several significant contributions to understanding autoimmune hepatitis including writing most of the clinical guidelines on the treatment.
According to a release, “With his colleagues at Mayo Clinic, he defines what remains the current standard of treatment for this disorder.”
More articles on gastroenterology/endoscopy:
Does integrating patient-reported outcomes into GI care improve patient satisfaction? 3 study insights
GI leader to know: Dr. G. Richard Puente of Metropolitan Gastroenterology Associates
Cedars-Sinai receives $10M for ‘decades-long, groundbreaking’ inflammatory bowel disease study: 4 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
